Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Yuling Xie, Ph.D. (she/her/hers)
Vertex Pharmaceuticals, Inc.
Poster(s):
(T1030-09-62) Interconversion Kinetic Study to Assess Class II Atropisomeric Drug Development Challenges
Tuesday, October 24, 2023
10:30 AM – 11:30 AM
ET